ESAT-6 and HspX Improve the Effectiveness of BCG to Induce Human Dendritic Cells-Dependent Th1 and NK Cells Activation

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Marongiu, Laura ^a   Donini, Marta ^a   Toffali, Lara ^a   Zenaro, Elena ^a   Dusi, Stefano ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CD45RO ANTIGEN; CD69 ANTIGEN; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; HEAT SHOCK PROTEIN; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 17AF; TOLL LIKE RECEPTOR 2; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; BCG VACCINATION; CD4+ T LYMPHOCYTE; CELL MATURATION; CELLULAR IMMUNITY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOKINE RESPONSE; DENDRITIC CELL; DRUG EFFICACY; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; NATURAL KILLER CELL; TH1 CELL;

ANTIGENS, BACTERIAL; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; BACTERIAL PROTEINS; BCG VACCINE; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-12; KILLER CELLS, NATURAL; LECTINS, C-TYPE;

EID: 84885161067     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075684     Document Type: Article

References (57)

1. Zenaro E, Donini M, Dusi S, (2009) Induction of Th1/Th17 immune response by Mycobacterium tuberculosis: role of dectin-1, Mannose Receptor, and DC-SIGN. J Leukoc Biol 86: 1393-1401.
2. Mariotti S, Teloni R, Iona E, Fattorini L, Romagnoli G, et al. (2004) Mycobacterium tuberculosis diverts alpha interferon-induced monocyte differentiation from dendritic cells into immunoprivileged macrophage-like host cells. Infect Immun 72: 4385-4392.
3. Geijtenbeek TB, Van Vliet SJ, Koppel EA, Sanchez-Hernandez M, Vandenbroucke-Grauls CM, et al. (2003) Mycobacteria target DC-SIGN to suppress dendritic cell function. J Exp Med 197: 7-17.
4. van Kooyk Y, Geijtenbeek TB, (2003) DC-SIGN: escape mechanism for pathogens. Nat Rev Immunol 3: 697-709.
5. Ize B, Palmer T, (2006) Microbiology. Mycobacteria's export strategy. Science 313: 1583-1584.
6. Siddiqui KF, Amir M, Agrewala JN, (2011) Understanding the biology of 16 kDa antigen of Mycobacterium tuberculosis: scope in diagnosis, vaccine design and therapy. Crit Rev Microbiol 37: 349-357.
7. Ganguly N, Siddiqui I, Sharma P, (2008) Role of M. tuberculosis RD-1 region encoded secretory proteins in protective response and virulence. Tuberculosis (Edinb) 88: 510-517.
8. Geluk A, Lin MY, van Meijgaarden KE, Leyten EM, Franken KL, et al. (2007) T-cell recognition of the HspX protein of Mycobacterium tuberculosis correlates with latent M. tuberculosis infection but not with M. bovis BCG vaccination. Infect Immun 75: 2914-2921.
9. Hu Y, Movahedzadeh F, Stoker NG, Coates AR, (2006) Deletion of the Mycobacterium tuberculosis alpha-crystallin-like hspX gene causes increased bacterial growth in vivo. Infect Immun 74: 861-868.
10. Brodin P, de Jonge MI, Majlessi L, Leclerc C, Nilges M, et al. (2005) Functional analysis of early secreted antigenic target-6, the dominant T-cell antigen of Mycobacterium tuberculosis, reveals key residues involved in secretion, complex formation, virulence, and immunogenicity. J Biol Chem 280: 33953-33959.
11. Hsu T, Hingley-Wilson SM, Chen B, Chen M, Dai AZ, et al. (2003) The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue. Proc Natl Acad Sci U S A 100: 12420-12425.
12. de Jonge MI, Pehau-Arnaudet G, Fretz MM, Romain F, Bottai D, et al. (2007) ESAT-6 from Mycobacterium tuberculosis dissociates from its putative chaperone CFP-10 under acidic conditions and exhibits membrane-lysing activity. J Bacteriol 189: 6028-6034.
13. Mishra BB, Moura-Alves P, Sonawane A, Hacohen N, Griffiths G, et al. (2010) Mycobacterium tuberculosis protein ESAT-6 is a potent activator of the NLRP3/ASC inflammasome. Cell Microbiol 12: 1046-1063.
14. Romagnoli A, Etna MP, Giacomini E, Pardini M, Remoli ME, et al. (2012) ESX-1 dependent impairment of autophagic flux by Mycobacterium tuberculosis in human dendritic cells. Autophagy 8: 1357-1370.
15. Ulrichs T, Munk ME, Mollenkopf H, Behr-Perst S, Colangeli R, et al. (1998) Differential T cell responses to Mycobacterium tuberculosis ESAT6 in tuberculosis patients and healthy donors. Eur J Immunol 28: 3949-3958.
16. Wu B, Huang C, Kato-Maeda M, Hopewell PC, Daley CL, et al. (2008) IL-9 is associated with an impaired Th1 immune response in patients with tuberculosis. Clin Immunol 126: 202-210.
17. Xu J, Xu W, Chen X, Zhao D, Wang Y, (2008) Recombinant DNA vaccine of the early secreted antigen ESAT-6 by Mycobacterium tuberculosis and Flt3 ligand enhanced the cell-mediated immunity in mice. Vaccine 26: 4519-4525.
18. Yuan W, Dong N, Zhang L, Liu J, Lin S, et al. (2012) Immunogenicity and protective efficacy of a tuberculosis DNA vaccine expressing a fusion protein of Ag85B-Esat6-HspX in mice. Vaccine 30: 2490-2497.
19. Bennekov T, Dietrich J, Rosenkrands I, Stryhn A, Doherty TM, et al. (2006) Alteration of epitope recognition pattern in Ag85B and ESAT-6 has a profound influence on vaccine-induced protection against Mycobacterium tuberculosis. Eur J Immunol 36: 3346-3355.
20. Kamath AT, Rochat AF, Valenti MP, Agger EM, Lingnau K, et al. (2008) Adult-like anti-mycobacterial T cell and in vivo dendritic cell responses following neonatal immunization with Ag85B-ESAT-6 in the IC31 adjuvant. PLoS One 3: e3683.
21. Kamath AT, Valenti MP, Rochat AF, Agger EM, Lingnau K, et al. (2008) Protective anti-mycobacterial T cell responses through exquisite in vivo activation of vaccine-targeted dendritic cells. Eur J Immunol 38: 1247-1256.
22. Wang X, Barnes PF, Dobos-Elder KM, Townsend JC, Chung YT, et al. (2009) ESAT-6 inhibits production of IFN-gamma by Mycobacterium tuberculosis-responsive human T cells. J Immunol 182: 3668-3677.
23. Brewer TF, (2000) Preventing tuberculosis with bacillus Calmette-Guerin vaccine: a meta-analysis of the literature. Clin Infect Dis 31Suppl 3: S64-67.
24. Spratt JM, Britton WJ, Triccas JA, (2010) In vivo persistence and protective efficacy of the bacille Calmette Guerin vaccine overexpressing the HspX latency antigen. Bioeng Bugs 1: 61-65.
25. Majlessi L, Brodin P, Brosch R, Rojas MJ, Khun H, et al. (2005) Influence of ESAT-6 secretion system 1 (RD1) of Mycobacterium tuberculosis on the interaction between mycobacteria and the host immune system. J Immunol 174: 3570-3579.
26. Li Q, Yu H, Zhang Y, Wang B, Jiang W, et al. (2011) Immunogenicity and protective efficacy of a fusion protein vaccine consisting of antigen Ag85B and HspX against Mycobacterium tuberculosis infection in mice. Scand J Immunol 73: 568-576.
27. Kong CU, Ng LG, Nambiar JK, Spratt JM, Weninger W, et al. (2011) Targeted induction of antigen expression within dendritic cells modulates antigen-specific immunity afforded by recombinant BCG. Vaccine 29: 1374-1381.
28. Taylor JL, Wieczorek A, Keyser AR, Grover A, Flinkstrom R, et al. (2012) HspX-mediated protection against tuberculosis depends on its chaperoning of a mycobacterial molecule. Immunol Cell Biol.
29. Ottenhoff TH, Kaufmann SH, (2012) Vaccines against tuberculosis: where are we and where do we need to go? PLoS Pathog 8: e1002607.
30. Esin S, Batoni G, Counoupas C, Stringaro A, Brancatisano FL, et al. (2008) Direct binding of human NK cell natural cytotoxicity receptor NKp44 to the surfaces of mycobacteria and other bacteria. Infect Immun 76: 1719-1727.
31. D'Andrea A, Rengaraju M, Valiante NM, Chehimi J, Kubin M, et al. (1992) Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J Exp Med 176: 1387-1398.
32. Presky DH, Minetti LJ, Gillessen S, Wilkinson VL, Wu CY, et al. (1998) Analysis of the multiple interactions between IL-12 and the high affinity IL-12 receptor complex. J Immunol 160: 2174-2179.
33. Pala P, Hussell T, Openshaw PJ, (2000) Flow cytometric measurement of intracellular cytokines. J Immunol Methods 243: 107-124.
34. Hespel C, Moser M, (2012) Role of inflammatory dendritic cells in innate and adaptive immunity. Eur J Immunol 42: 2535-2543.
35. Jacobs B, Wuttke M, Papewalis C, Seissler J, Schott M, (2008) Dendritic cell subtypes and in vitro generation of dendritic cells. Horm Metab Res 40: 99-107.
36. van Vliet SJ, den Dunnen J, Gringhuis SI, Geijtenbeek TB, van Kooyk Y, (2007) Innate signaling and regulation of Dendritic cell immunity. Curr Opin Immunol 19: 435-440.
37. Cooper AM, Khader SA, (2008) The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis. Immunol Rev 226: 191-204.
38. Annunziato F, Cosmi L, Santarlasci V, Maggi L, Liotta F, et al. (2007) Phenotypic and functional features of human Th17 cells. J Exp Med 204: 1849-1861.
39. Ziegler SF, Ramsdell F, Alderson MR, (1994) The activation antigen CD69. Stem Cells 12: 456-465.
40. Cooper AM, Solache A, Khader SA, (2007) Interleukin-12 and tuberculosis: an old story revisited. Curr Opin Immunol 19: 441-447.
41. Pathak SK, Basu S, Basu KK, Banerjee A, Pathak S, et al. (2007) Direct extracellular interaction between the early secreted antigen ESAT-6 of Mycobacterium tuberculosis and TLR2 inhibits TLR signaling in macrophages. Nat Immunol 8: 610-618.
42. Chatterjee S, Dwivedi VP, Singh Y, Siddiqui I, Sharma P, et al. (2011) Early secreted antigen ESAT-6 of Mycobacterium tuberculosis promotes protective T helper 17 cell responses in a toll-like receptor-2-dependent manner. PLoS Pathog 7: e1002378.
43. Bulut Y, Michelsen KS, Hayrapetian L, Naiki Y, Spallek R, et al. (2005) Mycobacterium tuberculosis heat shock proteins use diverse Toll-like receptor pathways to activate pro-inflammatory signals. J Biol Chem 280: 20961-20967.
44. Jo EK, Yang CS, Choi CH, Harding CV, (2007) Intracellular signalling cascades regulating innate immune responses to Mycobacteria: branching out from Toll-like receptors. Cell Microbiol 9: 1087-1098.
45. Sallusto F, Geginat J, Lanzavecchia A, (2004) Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 22: 745-763.
46. Ferlazzo G, Morandi B, D'Agostino A, Meazza R, Melioli G, et al. (2003) The interaction between NK cells and dendritic cells in bacterial infections results in rapid induction of NK cell activation and in the lysis of uninfected dendritic cells. Eur J Immunol 33: 306-313.
47. Andoniou CE, Coudert JD, Degli-Esposti MA, (2008) Killers and beyond: NK-cell-mediated control of immune responses. Eur J Immunol 38: 2938-2942.
48. Mihret A (2012) The role of dendritic cells in Mycobacterium tuberculosis infection. Virulence 3.
49. Marras F, Bozzano F, De Maria A, (2011) Involvement of activating NK cell receptors and their modulation in pathogen immunity. J Biomed Biotechnol 2011: 152430.
50. Annunziato F, Romagnani S, (2010) The transient nature of the Th17 phenotype. Eur J Immunol 40: 3312-3316.
51. Trinchieri G, (2003) Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3: 133-146.
52. Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM, et al. (2007) Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 8: 950-957.
53. Bettelli E, Oukka M, Kuchroo VK, (2007) T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol 8: 345-350.
54. Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F, (2007) Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 8: 942-949.
55. Khader SA, Pearl JE, Sakamoto K, Gilmartin L, Bell GK, et al. (2005) IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL-12p70 is available. J Immunol 175: 788-795.
56. North RJ, Jung YJ, (2004) Immunity to tuberculosis. Annu Rev Immunol 22: 599-623.
57. Khader SA, Gopal R, (2010) IL-17 in protective immunity to intracellular pathogens. Virulence 1: 423-427.